GREENWICH LIFESCIENCES, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-19.4M | $-17.4M | $-8.9M | $-7.8M | $-4.6M | $-1.9M | $-3.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $6.8M | $7.3M | $2.4M | $1.7M | $660.6K | $678.0K | $194.9K |
| Net Cash from Operating Activities | $-9.9M | $-7.3M | $-6.5M | $-6.2M | $-4.3M | $-1.2M | $-293.3K |
| Investing Activities | |||||||
| Capital Expenditures | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | $7.5M | — | — | — |
| Net Cash from Financing Activities | $12.0M | $4.4M | — | $-7.5M | $2.8M | $29.8M | $215.0K |
| Net Change in Cash | $2.1M | $-2.9M | $-6.5M | $-13.7M | $-1.5M | $28.7M | $-78.3K |
| Free Cash Flow | — | — | — | — | — | — | — |